Long
RARX Here I am and ready to party
Updated
Ra Pharmaceuticals to Present at the RBC Capital Markets 2018 Global Healthcare Conference
Ra Pharmaceuticals, Inc. (RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the RBC Capital Markets 2018 Global Healthcare Conference on Wednesday, February 21, 2018 at 8:00 a.m. E.T. The conference is being held at the Lotte New York Palace Hotel.
A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks,source: yahoo.com
Insider RA CAPITAL MANAGEMENT, LLC reports buying 2,500,000 shares of RRARX at $6.00 for a total cost of $15,000,000.00 fintel.io/n/us/rarx
Ra Pharmaceuticals, Inc. (RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the RBC Capital Markets 2018 Global Healthcare Conference on Wednesday, February 21, 2018 at 8:00 a.m. E.T. The conference is being held at the Lotte New York Palace Hotel.
A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks,source: yahoo.com
Insider RA CAPITAL MANAGEMENT, LLC reports buying 2,500,000 shares of RRARX at $6.00 for a total cost of $15,000,000.00 fintel.io/n/us/rarx
Note
Price moved as expected :)
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.